SKSirkka Keinänen-Kiukaanniemi

Sirkka Keinänen-Kiukaanniemi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sirkka Keinänen-Kiukaanniemi has a total of 198 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association of periodontal condition with insulin sensitivity – results of the Oulu1935 cohort study

    by Ville Myllymäki, Pekka Ylöstalo, Anna Liisa Suominen, Matti Knuuttila, Ulla Rajala, Sirkka Keinänen-Kiukaanniemi, Sirpa Anttila, Tuomas Saxlin

    Objective: To investigate whether baseline periodontal condition predicts reduced insulin sensitivity (RIS) over a follow-up period of about 15 years among participants with baseline euglycemia. Material and methods: A subpopulation (n = 224) of the Oulu1935 cohort was studied. Periodontal condition was defined by the presence and number of sites with periodontal pockets (probing pocket depth ≥ 4 mm) or by the participant being edentulous. Insulin sensitivity was measured using the Quantitative Insulin Sensitivity Check Index, with the lowest tertile indicating RIS. Rate ratios (RRs) with 95% confidence intervals (CI) were estimated using Poisson regression models with a robust error variance. Results: RIS was observed in 21.3% of the dentate participants without periodontal pockets, 32.8% of those with 1–6 sites with pockets, 33.3% of those with ≥ 7 sites with pockets, and 40.8% of the edentulous participants. Furthermore, adjusted RRs with 95% CIs (in parentheses) for the association of periodontal condition with RIS (reference: dentate participants without periodontal pockets) were 1.4 (0.8–2.6), 1.1 (0.6–2.1), and 1.4 (0.8–2.7), respectively. Conclusions: Poor periodontal condition and edentulousness predicted RIS. A healthy periodontium appears to support normal insulin function, but further studies are needed.

  • Open Access

    Association of insulin resistance and health-related quality of life with mild cognitive impairment during aging

    by Sanna Rotonen, Juha Auvinen, Aini Bloigu, Pirjo Härkönen, Jari Jokelainen, Markku Timonen, Sirkka Keinänen-Kiukaanniemi

    Previous studies have shown an association between dementia and diabetes. This study focused on examining whether insulin resistance is a risk factor for mild cognitive impairment (MCI). We also evaluated whether common cardiovascular risk factors or depressive symptoms modify the risk of MCI along with insulin resistance and compared the health-related quality of life (HRQoL) with or without MCI. The participants were followed from 57 to 69 years of age and divided into two groups, MCI and non-MCI, according to their Consortium to Establish a Registry for Alzheimer's Disease (CERAD) total score at the follow-up. The changes in Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) and fasting insulin level during the follow-up were determined. Smoking, alcohol consumption, physical activity, depressive symptoms, and HRQoL were obtained by questionnaire. Body weight, height, blood pressure, and low-density lipoprotein (LDL) cholesterol were measured at baseline and follow-up. Adjustments were made for baseline cognitive performance, professional education and physical activity. Greater increases in HOMA-IR (OR 2.20, 95% CI 1.05-4.62) and fasting insulin (OR 3.49, 95% CI 1.48-8.23) increased the risk of MCI. Lower cognitive performance at baseline (OR 6.33; 95% CI 3.27-12.29), lower level of education (OR 3.94, 95% CI 1.76-8.81) and lower level of physical activity (OR 2.44, 95% CI 1.06-5.65) also increased the risk of MCI at follow-up. There was a greater decline in health-related quality of life among the MCI group. Insulin resistance is a risk factor for MCI and MCI causes worsening of HRQoL during aging.

  • Open Access

    Impact of signs and symptoms of dry eye disease on health-related quality of life: a cross-sectional population study among older adults

    by Ulla Aapola, Paula Mosallaei, Janika Nättinen, Ilona Suurkuukka, Jaakko Tuomilehto, Sirkka Keinänen-Kiukaanniemi, Jouko Saramies, Hannu Uusitalo

    Purpose: To assess the relationship between quality of life (QoL) and ocular surface health within a Finnish population-based cohort. Methods: A cross-sectional study involved 601 individuals born between the years 1933–1956. Ocular surface health and dry eye disease (DED) were clinically evaluated using several diagnostic tests. Participants completed the Ocular Surface Disease Index (OSDI), QoL assessment with the 15D and Medical Outcomes Study 36-Item Short Form Health Survey (SF-36), and the Beck’s Depression Inventory (BDI-II) questionnaires. Various statistical methods were employed to explore the associations between QoL, ocular surface health, and sex disparities. Results: DED had negative impact on QoL in all participants, and especially in women. Adjusted for comorbidities, DED doubled the odds of worse health-related QoL (15D: OR = 2.31 [95% CI: 1.24–4.31, p < 0.01]) and mental health (SF-36 MCS and BDI-II: OR = 2.08 [95% CI: 1.04–4.16, p < 0.05]). Noninvasive tear break-up time (NIBUT) correlated with all QoL scores. In women, the most significant clinical signs correlating with low QoL were NIBUT (15D: r = 0.20, p = 0.002; SF-36 MCS: r = 0.18, p = 0.026), and conjunctival staining (15D: r=-0.19, p = 0.004; BDI-II: r = 0.27, p < 0.001), whereas in men, blepharitis correlated with depression score (BDI-II: r = 0.20, p = 0.036). High OSDI was associated with worse QoL in women, but not in men. Conclusion: This first population-based study assessing general QoL data with objective clinical measures of DED indicated that among elderly population, both symptoms and signs of DED independently impacted different aspects of QoL. In addition, significant sex-differences in these associations were observed and should be considered both in research settings and when assessing and treating people with DED.


  • Open Access

    Association of Periodontal Condition With Impaired Glucose Tolerance: Results of a 15‐Year Follow‐Up Study

    by Ville Myllymäki, Pekka Ylöstalo, Anna Liisa Suominen, Matti Knuuttila, Ulla Rajala, Sirkka Keinänen‐Kiukaanniemi, Sirpa Anttila, Tuomas Saxlin

    Objectives: The aim of this study was to investigate whether periodontal condition is associated with the development of impaired glucose tolerance (IGT).Material and Methods: This study was based on a subpopulation of a cohort of persons born in 1935 and living in Oulu, Finland, on October 1, 1990. The participants were normoglycemic (no previously diagnosed diabetes mellitus and a 2‐h oral glucose tolerance test [OGTT] blood glucose < 7.8 mmol/L) in the baseline examinations (1990–1992) and had fasting blood glucose < 7.0 mmol/L in the follow‐up examinations (2007–2008) (n = 225). The outcome was IGT on follow‐up, measured by a blood glucose level of ≥ 7.8 mmol/L after OGTT. The exposure was the periodontal condition at baseline categorized into four groups: 0, 1–6, ≥ 7 sites with deepened (≥ 4 mm) periodontal pockets, and edentulousness.Results: A total of 23% of the participants developed IGT. The adjusted incidence rate ratios with 95% confidence intervals (CI) for dentate participants with 1–6 sites and ≥ 7 sites with deepened periodontal pockets, and edentate participants (reference category dentate participants without deepened periodontal pockets) were 1.5 (95% CI, 0.6–4.0), 1.8 (95% CI, 0.7–4.4), and 1.6 (95% CI, 0.6–4.0), respectively.Conclusions: Poor periodontal condition may predispose individuals to IGT; however, further studies on this matter are warranted.


  • Open Access

    Women with a history of gestational diabetes mellitus present an accumulation of cardiovascular risk factors at age 46—A birth cohort study

    by Evi Bakiris, Kaisu Luiro, Jari Jokelainen, Laure Morin‐Papunen, Sirkka Keinänen‐Kiukaanniemi, Kari Kaikkonen, Terhi Piltonen, Juha S. Tapanainen, Juha Auvinen

    Introduction: The incidence of gestational diabetes mellitus (GDM) is globally increasing, and it has been associated with later type 2 diabetes, metabolic syndrome (MetS), and cardiovascular disease (CVD). However, long‐term population‐based studies investigating common CVD risk factors years after pregnancy are lacking. To evaluate the future mortality and morbidity in cardiovascular and metabolic diseases, we conducted a thorough investigation of midlife risk factors in women with and without previous GDM.Material and Methods: A prospective population‐based cohort study was conducted of 3173 parous women from the Northern Finland Birth Cohort, 1966. Study participants were obtained from the national register or patient records. Those with a GDM diagnosis formed the GDM cohort (n = 271), and those without a previous GDM diagnosis formed the control cohort (n = 2902). Clinical examinations were performed on participants at the age of 46 and included anthropometric measurements, oral glucose tolerance test (OGTT), biochemical measurements, and cardiovascular assessment.Results: At the age of 46, women in the GDM cohort had a higher body mass index (BMI, 29.0 kg/m2 vs 26.3 kg/m2, p < 0.001) and greater waist circumference (94.1 cm vs 86.5 cm, p < 0.001) than the control cohort. In the GDM cohort, a higher incidence of impaired glucose tolerance (12.6% vs 7.3%, p = 0.002), more previously diagnosed and OGTT‐detected type 2 diabetes (23.3% vs 3.9%, p < 0.001), lower high‐density lipoprotein (1.53 mmol/L vs 1.67 mmol/L, p = 0.011), higher triglycerides (1.26 mmol/L vs 1.05 mmol/L, p = 0.002) and a higher fatty liver index (6.82 vs 2.47, p < 0.001), were observed even after adjusting for BMI, polycystic ovary syndrome, parity, level of education, physical activity, smoking, and alcohol consumption. The women in the GDM cohort also had more MetS (42.6% vs 21.9%, p < 0.001) and higher risk scores for CVD and fatal events (Framingham 4.95 vs 3.60, p < 0.001; FINRISK 1.71 vs 1.08, p < 0.001).Conclusions: Women with a previous diagnosis of GDM exhibit more risk factors for CVD in midlife and are at a higher risk for cardiovascular events later in life.


  • Open Access

    Elevated One-Hour Post-Load Glucose Is Independently Associated with Albuminuria: A Cross-Sectional Population Study

    by Anni Saunajoki, Juha Auvinen, Aini Bloigu, Jouko Saramies, Jaakko Tuomilehto, Hannu Uusitalo, Esko Hussi, Henna Cederberg-Tamminen, Kadri Suija, Sirkka Keinänen-Kiukaanniemi, et al.

    The purpose of this study was to examine and compare the associations between albuminuria and fasting (FPG), 1 h post-load (1 h PG) and 2 h post-load plasma glucose (2 h PG) in an oral glucose tolerance test (OGTT). A total of 496 people free of known diabetes (mean age 72 years) participated in the examinations including the OGTT with plasma glucose measurements at 0, 1, and 2 h and levels of HbA1c. Albuminuria was determined by the urinary albumin-to-creatinine ratio and was defined as ≥3.0 mg/mmol. Compared with those without albuminuria, participants with albuminuria had significantly higher 1 h PG and 2 h PG levels, but not FPG or HbA1c levels. An elevated 1 h PG increased the estimated odds ratio of albuminuria more than three times in people with prediabetic 1 h PG (8.6–11.5 mmol/L: OR 3.60; 95% CI 1.70–7.64) and diabetic 1 h PG (≥11.6 mmol/L: OR 3.05; 95% CI 1.29–7.23). After adjusting for blood pressure and age, the association of elevated 1 h PG with albuminuria remained significant. Prediabetic or diabetic FPG, 2 h PG, or HbA1c did not have a statistically significant association with albuminuria. These findings suggest that 1 h PG seems to be the best glycemic parameter and is useful in recognizing persons with an elevated risk of early kidney disease due to hyperglycemia.


  • Open Access

    Association between accelerometer-measured physical activity, glucose metabolism, and waist circumference in older adults

    by Miia Länsitie, Maarit Kangas, Jari Jokelainen, Mika Venojärvi, Eeva Vaaramo, Pirjo Härkönen, Sirkka Keinänen-Kiukaanniemi, Raija Korpelainen


  • Open Access

    Systematic evaluation of the association between hemoglobin levels and metabolic profile implicates beneficial effects of hypoxia

    by Juha Auvinen, Joona Tapio, Ville Karhunen, Johannes Kettunen, Raisa Serpi, Elitsa Y. Dimova, Dipender Gill, Pasi Soininen, Tuija Tammelin, Juha Mykkänen, et al.

    Activation of the hypoxia-inducible factor (HIF) pathway reprograms energy metabolism. Hemoglobin (Hb) is the main carrier of oxygen. Using its normal variation as a surrogate measure for hypoxia, we explored whether lower Hb levels could lead to healthier metabolic profiles in mice and humans (n = 7175) and used Mendelian randomization (MR) to evaluate potential causality (n = 173,480). The results showed evidence for lower Hb levels being associated with lower body mass index, better glucose tolerance and other metabolic profiles, lower inflammatory load, and blood pressure. Expression of the key HIF target genes SLC2A4 and Slc2a1 in skeletal muscle and adipose tissue, respectively, associated with systolic blood pressure in MR analyses and body weight, liver weight, and adiposity in mice. Last, manipulation of murine Hb levels mediated changes to key metabolic parameters. In conclusion, low-end normal Hb levels may be favorable for metabolic health involving mild chronic activation of the HIF response.


  • Open Access

    PCSK9 Levels and Metabolic Profiles in Elderly Subjects with Different Glucose Tolerance under Statin Therapy

    by Kari A. Mäkelä, Jari Jokelainen, Ville Stenbäck, Juha Auvinen, Marjo-Riitta Järvelin, Mikko Tulppo, Juhani Leppäluoto, Sirkka Keinänen-Kiukaanniemi, Karl-Heinz Herzig

    Proprotein convertase subtilisin/kexin type 9 (PCSK9) degrades low-density lipoprotein cholesterol (LDL-C) receptors, and thus regulates the LDL-C levels in the circulation. Type 2 diabetics often have elevated LDL-C levels. However, the functions of PCSK9 in patients with alterations of glu-cose metabolism and statin therapy are still unclear. Method: we investigated a large cohort of 608 subjects, born in 1945 in Oulu, Finland (Oulu Cohort 1945). We studied the effects of PSCK9 lev-els with different glucose tolerances (normal glucose tolerance (NGT), prediabetes (PreDM) or type 2 diabetes (T2D)) with and without statin medication, and analyzed clinical data, NMR metabolomics and PCSK9 plasma levels. Results: PCSK9 plasma levels did not significantly differ between the three groups. Statin therapy significantly increased the PCSK9 levels in NGT, PreDM and T2D groups compared with subjects with no statins. In the NGT group, negative associations between PCSK9 and LDL-C, intermediate-density lipoprotein cholesterol (IDL-C), very low-density lipoprotein cholesterol (VLDL-C), total cholesterol and LDL and IDL triglycerides were observed under statin medication. In contrast, in the PreDM and T2D groups, these associa-tions were lost. Conclusions: our data suggest that in subjects with abnormal glucose metabolism and statin therapy, the significant PCSK9-mediated effects on the lipid metabolites are lost com-pared to NGT subjects, but statins reduced the LDL-C and VLDL-C levels.


  • Open Access

    Association of mitochondrial DNA haplogroups J and K with low response in exercise training among Finnish military conscripts

    by Jukka Kiiskilä, Jari Jokelainen, Laura Kytövuori, Ilona Mikkola, Pirjo Härkönen, Sirkka Keinänen-Kiukaanniemi, Kari Majamaa

    Background: We have previously suggested that some of the mutations defining mitochondrial DNA (mtDNA) haplogroups J and K produce an uncoupling effect on oxidative phosphorylation and thus are detrimental for elite endurance performance. Here, the association between haplogroups J and K and physical performance was determined in a population-based cohort of 1036 Finnish military conscripts.Results: Following a standard-dose training period, excellence in endurance performance was less frequent among subjects with haplogroups J or K than among subjects with non-JK haplogroups (p = 0.041), and this finding was more apparent among the best-performing subjects (p < 0.001).Conclusions: These results suggest that mtDNA haplogroups are one of the genetic determinants explaining individual variability in the adaptive response to endurance training, and mtDNA haplogroups J and K are markers of low-responders in exercise training.